Rybelsus (semaglutide) is a GLP-1 receptor agonist that does not cause physical dependence or withdrawal symptoms when stopped abruptly Discontinuing Rybelsus leads to rising blood glucose levels, increased appetite, and potential weight regain as the medication's effects diminish over 45 weeks Stopping without medical supervision and an alternative diabetes management plan increases risk of poor glycaemic control and long-term complications NICE and MHRA guidance recommend discussing any medication changes with your healthcare team to ensure continuity of diabetes management Safe discontinuation requires monitoring blood glucose levels, implementing lifestyle strategies, and potentially starting alternative medications under medical supervision Table of Contents What Happens When You Stop Taking Rybelsus Suddenly Rybelsus (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used to improve glycaemic control in adults with type 2 diabetes mellitus

The STEP trials, which followed over 4,500 participants, reported depression in fewer than 2% of semaglutide usersa rate similar to placebo groups
Free UK Delivery Free delivery to United Kingdom when spending over 20 Estimated Delivery Times United Kingdom: 1 business day Europe: 5 to 8 business days International: Delivery times vary depending on destination country and customs processing Order Tracking Tracking information is provided for eligible shipments once your order has been dispatched
When to contact a healthcare provider Mild skin irritation or tenderness may improve on its own, but its a good idea to contact a healthcare provider if symptoms become severe, persistent, or concerning